This project will consist of 1 large clinical trial with 3 core concepts: (1) Clinical benefits of an intensive rehabilitation programme using advanced technology, compared to the control group; (2) A full health economic evaluation combined with model-based estimation of costs and benefits; (3) process evaluation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
102
Intensive rehabilitation using advanced technology, based on the patient's goals. Including cardiovascular fitness training, goal-oriented training, physiotherapy with and without advanced technology and self-management.
AZ Herentals
Herentals, Belgium
KU Leuven
Leuven, Belgium
Change in Functional Independence Measure (FIM)
The Functional Independence Measure (FIM), which measures independence in daily functioning after stroke. The FIM consists of 18 items designed to assess to what extent a person needs assistance in performing activities of daily living safely and efficiently. The activities consist of a number of basic skills related to self-care, pelvic floor function, transfers, gait, communication and social abilities. The FIM has acceptable reliability and has been found valid in people with stroke. Min: 13; Max: 91; Higher = better
Time frame: Baseline - 3weeks - 9months
Change in Spinal Cord Independence Measure (SCIM)
Spinal Cord Independence Measure (SCIM), an assessment of achievements of daily function of patients with spinal cord lesions. The scale consists of 19 tasks organized in 3 subscales: self-care, respiration and sphincter management, and mobility. The SCIM is valid and reliable. Min: 0; Max: 100; Higher = better
Time frame: Baseline - 3weeks - 9months
Change in The Canadian Occupational Performance Measure (COPM)
The Canadian Occupational Performance Measure (COPM), is an evidence-based outcome measure designed to capture a patient's self-perception of performance in everyday living, over time. This outcome can be used in both study populations. Min: 1; Max: 10; Higher = better
Time frame: Baseline - 3weeks - 9months
Change in EQ-5D-5L
EQ-5D-5L, measures quality of life at five levels of health (mobility, self-care, daily activities, pain/discomfort and anxiety/depression). From this, a weighted health index can be calculated for an individual or population. This scale can also be used for both populations. Min: 1; Max: 100; Higher = better
Time frame: Baseline - 3weeks - every month during follow-up - 9 months
Change in Goal Attainment Scaling (GAS)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Goal Attainment Scaling (GAS), is an individualised evaluation method. It is scored on an ordinal 5-point scale, which captures a person's individual treatment goal and is scored afterwards on the achievement of that treatment goal. The GAS can and will be used for both stroke and spinal cord injury. Min: -2; Max: +2; Higher = better
Time frame: Baseline - 3weeks - 9months
Change in The fatigue severity scale (FSS)
The fatigue severity scale (FSS) contains 9 questions assessing the perceived severity of fatigue symptoms in the past week in various daily situations. The patient indicates the extent to which fatigue determines functioning. Again, this will be used for both stroke and spinal cord injury. Min: 9; Max: 63; Higher = worse
Time frame: Baseline - 3weeks - 9months
Borg Rating of Perceived Exertion Scale
During the intervention the Borg Rating of Perceived Exertion Scale will be completed to after every therapy block to assess subjective experiences of the patients during physical load. Min: 6; Max: 20; Higher = worse
Time frame: During intervention (up to 9 months)
Change in the 6-minute Walk-Test (6MWT)
The 6-minute Walk-Test (6MWT) is used to measure functional capacity. The maximum distance the patient can cover within 6 minutes is measured.
Time frame: Baseline - 3weeks - 9months (stroke only)
Change in the action research Arm Test (ARAT)
The action research Arm Test (ARAT) is an observational measure to assess upper extremity performance (coordination, dexterity and functioning), including 19 items. Task performance is rated on a 4-point scale, ranging from 0 (no movement) to 3 (movement performed normally). Min: 0; Max: 57; Higher = better
Time frame: Baseline - 3weeks - 9months (stroke only)
Change in rhe Fugl-Meyer Assessment (FMA)
The Fugl-Meyer Assessment (FMA) is designed to assess motor functioning in upper and lower limbs, in patients with post-stroke. Patients are assessed on 50 test items and on an ordinal 3-point scale. Min: 0; Max: 100; Higher = better
Time frame: Baseline - 3weeks - 9months (stroke only)
Change in the functional Ambulation Classification (FAC)
The functional Ambulation Classification (FAC): is a functional walking test that evaluates ambulation ability. This 6-point scale assesses ambulation status by determining how much human support the patient needs when walking, whether or not they use a personal assistive device. Min: 0; Max: 5; Higher = better
Time frame: Baseline - 3weeks - 9months (stroke only)
Change in the 10 Meter Walk Test (10MWT)
The 10 Meter Walk Test (10MWT) measures the time needed for a person to walk 10 meters. It is used to determine functional mobility and gait.
Time frame: Baseline - 3weeks - 9months (stroke only)
Change in the Stroke Self-efficacy Questionnaire
The Stroke Self-efficacy Questionnaire Evaluate individuals' confidence in carrying out activities of daily living. Min: 0; Max: 60; Higher = better
Time frame: Baseline - 3weeks - 9months (stroke only)